Clinical Trials Directory

Trials / Unknown

UnknownNCT03549182

Serotonin, Serotonin Genetics(TPH2) and Emotion and Interference Processing

The Influence of Acute Tryptophan Depletion on Emotion and Interference Processing and Potential Moderation by 5HT Genetics (TPH2)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University of Electronic Science and Technology of China · Academic / Other
Sex
Male
Age
18 Years – 30 Years
Healthy volunteers
Accepted

Summary

The study aims to explore whether acute tryptophan depletion can affect the emotion and interference processing whether this effect is moderated by the TPH2 genotype

Detailed description

Based on previous studies suggesting that serotonin, a neurotransmitter, is associated with social \& emotional behavior, including emotional reactivity and emotion regulation, the present study aims to explore effects of acute tryptophan depletion (ATD) on emotion processing and emotional interference processing within a randomized double-blind, with-subject, placebo-controlled pharmaco-fMRI experiment. To further examine the potential moderating effects of the genetic makeup of the serotonin system the present study will include a pharmacogenetics imaging approach. Given that TPH2 is the key regulator of the serotonergic signaling pathway, we therefore assessed whether such the effects of tryptophan depletion vary according to the TPH2 genotype. To this end, healthy male TPH2-GG or TPH2-TT carriers will be recruited and will receive ATD (100g) and placebo (102.3g) in a within subject design. To control for potential effects of pre-medication personality traits as well as effects of medicines on mood, subjects will be administered pre-treatment assessing relevant personality traits and post-treatment assessments of mood.

Conditions

Interventions

TypeNameDescription
DRUGATD treatmentoral administration of ATD (100g)(Acute Tryptophan Depletion)
DRUGplacebo treatmentoral administration of placebo (102.3g)

Timeline

Start date
2017-03-01
Primary completion
2021-06-01
Completion
2021-12-01
First posted
2018-06-07
Last updated
2020-12-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03549182. Inclusion in this directory is not an endorsement.